Effect of complement C5 on apotosis in experimental autoimmune encephalomyelitis

被引：0
|
作者：
Niculescu, T
Weerth, S
Niculescu, F
Rus, V
Raine, CS
Shin, ML
Rus, H
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
来源：
MOLECULAR IMMUNOLOGY | 2003年 / 40卷 / 2-4期
关键词：
C5b-9 terminal complex; apoptosis;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：179 / 180
页数：2
相关论文
共 50 条
  • [21] Effect a minocycline in experimental autoimmune encephalomyelitis
    Nessler, S
    Dodel, R
    Bittner, A
    Reuss, S
    Du, YS
    Hemmer, B
    Sommer, N
    ANNALS OF NEUROLOGY, 2002, 52 (05) : 689 - 690
  • [22] Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease
    Szalai, Alexander J.
    Hu, Xianzhen
    Adams, Jillian E.
    Barnum, Scott R.
    MOLECULAR IMMUNOLOGY, 2007, 44 (12) : 3132 - 3136
  • [23] ROLE OF IGG AND COMPLEMENT COMPONENT C5 IN THE INITIAL COURSE OF EXPERIMENTAL CRYPTOCOCCOSIS
    DROMER, F
    PERRONNE, C
    BARGE, J
    VILDE, JL
    YENI, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1989, 78 (03): : 412 - 417
  • [24] THE INHIBITORY EFFECT OF ROSMARINIC ACID ON COMPLEMENT INVOLVES THE C5 CONVERTASE
    PEAKE, PW
    PUSSELL, BA
    MARTYN, P
    TIMMERMANS, V
    CHARLESWORTH, JA
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 (07): : 853 - 857
  • [25] C5 DEFICIENCY PREVENTS EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)
    CHRISTADOSS, P
    MAKRIDES, W
    FEDERATION PROCEEDINGS, 1987, 46 (04) : 1377 - 1377
  • [26] Structure/function of C5 convertases of complement
    Rawal, N
    Pangburn, MK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (03) : 415 - 422
  • [27] Crystallization of human complement component C5
    Discipio, RG
    Jenner, L
    Thirup, S
    Sottrup-Jensen, L
    Nyborg, J
    Stura, E
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1998, 54 : 643 - 646
  • [28] Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis
    Reiman, R
    Torres, AC
    Martin, BK
    Ting, JP
    Campbell, LL
    Barnum, SR
    NEUROSCIENCE LETTERS, 2005, 390 (03) : 134 - 138
  • [29] Coversin, a novel complement C5 inhibitor and potential therapeutic agent, prevents C5 activation in patients with C5 polymorphisms
    Mackie, I. J.
    Chitolie, A.
    Nunn, M.
    Weston-Davies, W.
    Machin, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 153 - 154
  • [30] The role of the complement system in the pathogenesis of experimental autoimmune encephalomyelitis and multiple sclerosis
    Terenyi, Nora
    Prechl, Jozsef
    Erdei, Anna
    CURRENT TOPICS IN COMPLEMENT, 2006, 586 : 177 - 188
12345